Valtrex

Valsts: Armēnija

Valoda: angļu

Klimata pārmaiņas: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Aktīvā sastāvdaļa:

valaciclovir (valaciclovir hydrochloride)

Pieejams no:

GlaxoSmithKline Pharmaceuticals SA

SNN (starptautisko nepatentēto nosaukumu):

valaciclovir (valaciclovir hydrochloride)

Deva:

500mg

Zāļu forma:

tablets film-coated

Receptes veids:

Prescription

Lietošanas instrukcija

QUALITATIVE AND QUANTITATIVE COMPOSITION
Film-coated tablets containing 250 mg, 500 mg or 1000 mg of
valaciclovir.
PHARMACEUTICAL FORM
Film-coated tablets.
CLINICAL PARTICULARS
INDICATIONS
_VALTREX_ is indicated for the treatment of herpes zoster (shingles).
_VALTREX_ accelerates the resolution of pain: it reduces the duration
of and the proportion of patients with zoster-associated pain, which
includes acute and post-herpetic neuralgia.
_VALTREX_ is indicated for the treatment of herpes simplex infections
of the skin and mucous membranes, including initial and recurrent
genital herpes.
_VALTREX_ is indicated for the treatment of herpes labialis (cold
sores).
_VALTREX_ is indicated for the prevention (suppression) of recurrent
herpes simplex infections of the skin and mucous membranes,
including genital herpes.
_VALTREX_ can reduce transmission of genital herpes when taken as
suppressive therapy and combined with safer sex practices.
_VALTREX_ is indicated for the prophylaxis of cytomegalovirus (CMV)
infection and disease, following organ transplantation. CMV
prophylaxis with _VALTREX_ reduces acute graft rejection (renal
transplant patients), opportunistic infections and other herpes virus
infections (herpes simplex virus (HSV), varicella zoster virus (VZV)).
DOSAGE AND ADMINISTRATION
·
ADULTS
TREATMENT OF HERPES ZOSTER (SHINGLES) INCLUDING OPHTHALMIC ZOSTER
The dosage is 1000 mg of _VALTREX_ to be taken three times daily for
seven days.
TREATMENT OF HERPES SIMPLEX INFECTIONS
_IMMUNOCOMPETENT ADULTS AND ADOLESCENTS (12 YEARS AND OLDER)_
The dosage is 500 mg of _VALTREX_ to be taken twice daily.
For recurrent episodes, treatment should be for three or five days.
For initial episodes, which can be more severe, treatment may have
to be extended from five days to ten days. Dosing should begin
as early as possible. For recurrent episodes of herpes simplex, this
should ideally be during the prodromal period or immediately
the first signs or symptoms appear._ VALTREX_ can prevent lesion
development when taken at the f

Produkta apraksts

SUMMARY OF PRODUCT CHARACTERISTICS
VALTREX™
Valaciclovir
QUALITATIVE AND QUANTITATIVE COMPOSITION
Film-coated tablets containing 250 mg, 500 mg or 1000 mg of
valaciclovir.
PHARMACEUTICAL FORM
Film-coated tablets.
CLINICAL PARTICULARS
INDICATIONS
_VALTREX_ is indicated for the treatment of herpes zoster (shingles).
_VALTREX_ accelerates
the resolution of pain: it reduces the duration of and the proportion
of patients with
zoster-associated pain, which includes acute and post-herpetic
neuralgia.
_VALTREX_ is indicated for the treatment of herpes simplex infections
of the skin and
mucous membranes, including initial and recurrent genital herpes.
_VALTREX_ is indicated for the treatment of herpes labialis (cold
sores).
_VALTREX_ is indicated for the prevention (suppression) of recurrent
herpes simplex
infections of the skin and mucous membranes, including genital herpes.
_VALTREX_ can reduce transmission of genital herpes when taken as
suppressive therapy
and combined with safer sex practices.
_VALTREX_ is indicated for the prophylaxis of cytomegalovirus (CMV)
infection and
disease, following organ transplantation. CMV prophylaxis with
_VALTREX_ reduces acute
graft rejection (renal transplant patients), opportunistic infections
and other herpes virus
infections (herpes simplex virus (HSV), varicella zoster virus (VZV)).
DOSAGE AND ADMINISTRATION

ADULTS
TREATMENT OF HERPES ZOSTER (SHINGLES) INCLUDING OPHTHALMIC ZOSTER
The dosage is 1000 mg of _VALTREX_ to be taken three times daily for
seven days.
TREATMENT OF HERPES SIMPLEX INFECTIONS
_IMMUNOCOMPETENT ADULTS AND ADOLESCENTS (12 YEARS AND OLDER) _
The dosage is 500 mg of _VALTREX_ to be taken twice daily.
For recurrent episodes, treatment should be for three or five days.
For initial episodes,
which can be more severe, treatment may have to be extended from five
days to ten days.
Dosing should begin as early as possible. For recurrent episodes of
herpes simplex, this
should ideally be during the prodromal period or immediately the first
signs or symptoms
appear.